217 related articles for article (PubMed ID: 31793333)
21. Bovine and porcine heparins: different drugs with similar effects on human haemodialysis.
Tovar AM; Teixeira LA; Rembold SM; Leite M; Lugon JR; Mourão PA
BMC Res Notes; 2013 Jun; 6():230. PubMed ID: 23763719
[TBL] [Abstract][Full Text] [Related]
22. Converting the Distinct Heparins Sourced from Bovine or Porcine Mucosa into a Single Anticoagulant Drug.
Tovar AMF; Vairo BC; Oliveira SMCG; Glauser BF; Santos GRC; Capillé NV; Piquet AA; Santana PS; Micheli KVA; Pereira MS; Vilanova E; Mourão PAS
Thromb Haemost; 2019 Apr; 119(4):618-632. PubMed ID: 30791055
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
[TBL] [Abstract][Full Text] [Related]
24. Characterization of PF4-Heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential.
Bertini S; Fareed J; Madaschi L; Risi G; Torri G; Naggi A
Clin Appl Thromb Hemost; 2017 Oct; 23(7):725-734. PubMed ID: 28118750
[TBL] [Abstract][Full Text] [Related]
25. Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?
Aquino RS; Pereira MS; Vairo BC; Cinelli LP; Santos GR; Fonseca RJ; Mourão PA
Thromb Haemost; 2010 May; 103(5):1005-15. PubMed ID: 20216993
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
[TBL] [Abstract][Full Text] [Related]
27. Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools.
Monakhova YB; Diehl BWK; Fareed J
J Pharm Biomed Anal; 2018 Feb; 149():114-119. PubMed ID: 29112899
[TBL] [Abstract][Full Text] [Related]
28. Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin.
Baytas SN; Varghese SS; Jin W; Yu Y; He P; Douaisi M; Zhang F; Brodfuehrer P; Xia K; Dordick JS; Linhardt RJ
J Med Chem; 2021 Feb; 64(4):2242-2253. PubMed ID: 33586962
[TBL] [Abstract][Full Text] [Related]
29. Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes.
Lean QY; Gueven N; Eri RD; Bhatia R; Sohal SS; Stewart N; Peterson GM; Patel RP
Expert Rev Clin Pharmacol; 2015; 8(6):795-811. PubMed ID: 26308504
[TBL] [Abstract][Full Text] [Related]
30. From unfractionated heparins to low molecular weight heparins.
Hirsh J
Acta Chir Scand Suppl; 1990; 556():42-50. PubMed ID: 1705072
[TBL] [Abstract][Full Text] [Related]
31. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin.
Douaisi M; Paskaleva EE; Fu L; Grover N; McManaman CL; Varghese S; Brodfuehrer PR; Gibson JM; de Joode I; Xia K; Brier MI; Simmons TJ; Datta P; Zhang F; Onishi A; Hirakane M; Mori D; Linhardt RJ; Dordick JS
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2315586121. PubMed ID: 38498726
[TBL] [Abstract][Full Text] [Related]
33. Comparative Pharmacokinetic Profile of 3 Batches of Ovine Low-Molecular-Weight Heparin and 1 Batch of Branded Enoxaparin.
Jeske W; Kouta A; Duff R; Rangnekar V; Niverthi M; Hoppensteadt D; Fareed J; Yao Y
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):150S-156S. PubMed ID: 30198315
[TBL] [Abstract][Full Text] [Related]
34. Immunochemical control of the species origin of porcine crude heparin and detection of ovine and caprine materials.
Levieux A; Rivera V; Levieux D
J Pharm Biomed Anal; 2002 Jan; 27(1-2):305-13. PubMed ID: 11682238
[TBL] [Abstract][Full Text] [Related]
35. General Considerations for Diversifying Heparin Drug Products by Improving the Current Heparin Manufacturing Process and Reintroducing Bovine Sourced Heparin to the US Market.
Al-Hakim A
Clin Appl Thromb Hemost; 2021; 27():10760296211052293. PubMed ID: 34894779
[TBL] [Abstract][Full Text] [Related]
36. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D
Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630
[TBL] [Abstract][Full Text] [Related]
37. Antimetastatic activities of heparins and modified heparins. Experimental evidence.
Borsig L
Thromb Res; 2010 Apr; 125 Suppl 2():S66-71. PubMed ID: 20434009
[TBL] [Abstract][Full Text] [Related]
38. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
Peyrou V; Béguin S; Boneu B; Hemker HC
Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
[TBL] [Abstract][Full Text] [Related]
39. The complex effects of heparins on cancer progression and metastasis in experimental studies.
Smorenburg SM; Van Noorden CJ
Pharmacol Rev; 2001 Mar; 53(1):93-105. PubMed ID: 11171940
[TBL] [Abstract][Full Text] [Related]
40. Heparin: from animal organ extract to designer drug.
Middeldorp S
Thromb Res; 2008; 122(6):753-62. PubMed ID: 17996279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
